masoprocol and Obesity

masoprocol has been researched along with Obesity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arshad, S; Azhar, S; Bittner, S; Cortez, Y; Dong, D; Dulay, H; Han, L; Kraemer, FB; Shen, WJ1
Hwang, JK; Jo, K; Kim, D; Lee, MS1

Other Studies

2 other study(ies) available for masoprocol and Obesity

ArticleYear
Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH).
    Molecular and cellular endocrinology, 2019, 12-01, Volume: 498

    Topics: Animals; Antioxidants; Diet, High-Fat; Disease Models, Animal; Hyperlipidemias; Inflammation; Insulin Resistance; Larrea; Lipogenesis; Male; Masoprocol; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress

2019
Nordihydroguaiaretic acid protects against high-fat diet-induced fatty liver by activating AMP-activated protein kinase in obese mice.
    Biochemical and biophysical research communications, 2010, Oct-08, Volume: 401, Issue:1

    Topics: Adiposity; AMP-Activated Protein Kinases; Animals; Diet; Dietary Fats; Fatty Liver; Hepatocytes; Insulin; Lipoxygenase Inhibitors; Male; Masoprocol; Mice; Mice, Inbred C57BL; Obesity; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Triglycerides; Weight Gain

2010